Sarcopenic Obesity in Neurodisabilities

Dionyssiotis, Yannis, M.D.150 enrolled

Overview

To describe the frequency and thresholds for sarcopenic obesity in neurodisabled persons and the fat and lean mass distribution based on various neurodisabilities

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Sarcopenic Obesity Spinal Cord Injuries Stroke Multiple Sclerosis Traumatic Brain Injury

Interventions

whole body DXADIAGNOSTIC_TEST

Measurements of body composition may be used to study how lean body mass and body fat change during health and disease and have provided a research tool to study the metabolic effects of obesity and various wasting conditions. DXA measurements are based in part on the assumption that the hydration of fat-free mass remains constant at 73%.

Eligibility

Sex: ALLMin age: 20 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Persons with * stroke / cerebrovascular disease * traumatic brain injury * multiple sclerosis * spinal cord injuries (including spinal cord lesions i.e. myelopathies etc.) Exclusion Criteria: Persons with * heterotopic ossifications, * chronic administration of drugs, which promote fat increase * chronic administration of drugs, which promote bone or muscle loss * co-existing other diseases such as: endocrinopathies, muscular dystrophies, non-alcoholic fatty liver disease.

Locations (1)

National Rehabilitation Center EKA

Nea Liosia, Athens, Greece

Outcomes

Primary Outcomes

Fat and lean mass in neurodisabled

Time frame: an average of 1 year

Frequency of sarcopenic obesity

Time frame: an average of 1 year

Secondary Outcomes

Body mass index correlation with fat mass and visceral fat

Time frame: an average of 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.